Teva Pharmaceutical Ind Ltd. – Investors and Politicians Who Own It

TEVA

Investors who own it

11 tracked investors, $1.1B in shares, each from their latest 13F.

InvestorValueShare of portfolio
David RosenRubric Capital Management, Q2 2026
$527.7M4.84%
Anand ParekhAlyeska Investment Group, Q2 2026
$212M0.55%
Larry RobbinsGlenview Capital Management, Q2 2026
$172.1M3.13%
$81.5M0.05%
Ray DalioBridgewater Associates, Q2 2026
$44.9M0.18%
Stanley DruckenmillerDuquesne Family Office, Q2 2026
$21.2M0.41%
Daniel SchneebergerADAR1 Capital Management, Q2 2026
$9.4M0.43%
Cathie WoodARK Investment Management, Q2 2026
$2.3M0.02%
Mario GabelliGAMCO Investors, Q2 2026
$2.2M0.02%
$1.4M0.01%
Barry RitholtzRitholtz Wealth Management, Q2 2026
$694.2K0.01%

Politicians who own it

Estimated from annual disclosures and trades; values are rough estimates.

PoliticianEst. valueShare of portfolio
Alan ArmstrongR-OK · Senate
$11.1K0.22%
InvestorActionShares now
Andreas HalvorsenNew7,567,533
David GreenspanReduced −32%13,668,233
Jeremy GranthamReduced −99%18,792
National Pension Service (Korea)Added +107%3,170,640
Zach SchreiberAdded +6.7%9,758,344
Stanley DruckenmillerNew1,427,950
David RosenReduced −7.3%16,005,498
Larry RobbinsReduced −7.7%8,456,324
Anand ParekhReduced −5.3%3,625,000
Barry RitholtzAdded +270%41,643
Cathie WoodReduced −27%123,865
Daniel SchneebergerAdded +4.9%108,171
Lee AinslieAdded +5.0%68,779
Mario GabelliReduced −3.4%129,700
Ray DalioAdded +5.2%23,222

Politicians trading it

Latest Congress trades disclosed under the STOCK Act; amounts are ranges.

PoliticianActionTraded
Alan ArmstrongR-OK · Senate
Bought$1K–$15KMar 30, 2026disclosed Jul 21, 2026